Gatekeeping Drugs
By David A. Simon. In this Article, Professor Simon proposes a thought experiment to evaluate proposals to lower drug approval standards: extend the system of off-label reimbursement across all drug regulation. Using this approach, he identifies significant costs and benefits to…
